Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amsterdam UMC Ventures is the dedicated venture capital and holding arm of the Amsterdam University Medical Centers (Amsterdam UMC). Founded in 1995 to drive the valorization of scientific research, the company specializes in transforming academic breakthroughs into commercial enterprises through the creation and support of spin-off companies. Its portfolio spans a diverse range of medical sectors, including biopharmaceuticals, medical devices, and digital health diagnostics. The organization operates in close collaboration with the Innovation Exchange Amsterdam (IXA) to provide legal, financial, and strategic governance to early-stage ventures. As of 2025, the team manages these activities under the umbrella of Amsterdam Academic Ventures (AAV), which integrates holdings from several Amsterdam-based knowledge institutes. Amsterdam UMC Ventures aims to generate both societal impact and financial returns to reinvest in future medical innovations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amsterdam UMC Ventures.